In the presentation titled, "Oncogenic human papillomavirus hijacks p300 to drive viral transcription, creating a therapeutic vulnerability that can be exploited with selective p300/CBP catalytic ...
Kronos Bio (KRON) announced preclinical data from its p300 KAT inhibitor program for human papillomavirus-driven tumors at the EORTC-NCI-AACR ...
Experience AI-powered efficiency and robust security designed for modern achievers - now available in Canada, starting from ...